MX2014010940A - El uso de antitrombina en el tratamiento de preeclampsia. - Google Patents

El uso de antitrombina en el tratamiento de preeclampsia.

Info

Publication number
MX2014010940A
MX2014010940A MX2014010940A MX2014010940A MX2014010940A MX 2014010940 A MX2014010940 A MX 2014010940A MX 2014010940 A MX2014010940 A MX 2014010940A MX 2014010940 A MX2014010940 A MX 2014010940A MX 2014010940 A MX2014010940 A MX 2014010940A
Authority
MX
Mexico
Prior art keywords
eclampsia
antithrombin
treatment
atrynâ
disclosure provides
Prior art date
Application number
MX2014010940A
Other languages
English (en)
Spanish (es)
Inventor
Johan Frieling
Simon Lowry
Original Assignee
Lfb Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lfb Usa Inc filed Critical Lfb Usa Inc
Publication of MX2014010940A publication Critical patent/MX2014010940A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2014010940A 2012-03-12 2013-03-12 El uso de antitrombina en el tratamiento de preeclampsia. MX2014010940A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261609534P 2012-03-12 2012-03-12
PCT/US2013/030350 WO2013138271A1 (en) 2012-03-12 2013-03-12 The use of antithrombin in the treatment of pre-eclampsia

Publications (1)

Publication Number Publication Date
MX2014010940A true MX2014010940A (es) 2015-04-13

Family

ID=49161701

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014010940A MX2014010940A (es) 2012-03-12 2013-03-12 El uso de antitrombina en el tratamiento de preeclampsia.

Country Status (12)

Country Link
US (1) US20140206617A1 (enExample)
EP (1) EP2825194A4 (enExample)
JP (1) JP2015509984A (enExample)
KR (1) KR20140135219A (enExample)
CN (1) CN104321076A (enExample)
AR (1) AR090315A1 (enExample)
AU (1) AU2013203512B2 (enExample)
CA (1) CA2871159A1 (enExample)
IN (1) IN2014DN08385A (enExample)
MX (1) MX2014010940A (enExample)
TW (1) TW201400499A (enExample)
WO (1) WO2013138271A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3834851A1 (en) 2010-12-30 2021-06-16 Laboratoire Français du Fractionnement et des Biotechnologies Glycols as pathogen inactive agents
KR20150039201A (ko) 2012-08-03 2015-04-09 엘에프비 유에스에이, 인크. 체외 막 산소공급에서의 안티트롬빈의 용도
ES2755181T3 (es) 2013-02-13 2020-04-21 Lab Francais Du Fractionnement Anticuerpos anti-TNF-alfa altamente galactosilados y usos de los mismos
EP2956003A2 (en) 2013-02-13 2015-12-23 Laboratoire Français du Fractionnement et des Biotechnologies Proteins with modified glycosylation and methods of production thereof
JP2016532100A (ja) 2013-07-05 2016-10-13 ラボラトワール・フランセ・デュ・フラクシオンマン・エ・デ・ビョテクノロジーＬａｂｏｒａｔｏｉｒｅ Ｆｒａｎｃａｉｓ Ｄｕ Ｆｒａｃｔｉｏｎｎｅｍｅｎｔ Ｅｔ Ｄｅｓ Ｂｉｏｔｅｃｈｎｏｌｏｇｉｅｓ アフィニティークロマトグラフィーマトリックス
FR3038517B1 (fr) 2015-07-06 2020-02-28 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Utilisation de fragments fc modifies en immunotherapie
WO2021073518A1 (zh) * 2019-10-17 2021-04-22 中国科学院动物研究所 纤溶酶抑制因子的抑制剂用于预防或治疗子痫前期或子痫的用途
CN113406326B (zh) * 2021-06-01 2022-08-26 大连医科大学 一种用于预测子痫前期的生物学标志物及其应用
CN118593717A (zh) * 2024-05-31 2024-09-06 厦门特宝生物工程股份有限公司 一种用于治疗和/或预防子痫前期发生的药物组合物及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122007000007I1 (de) 1986-04-09 2007-05-16 Genzyme Corp Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern
NZ241954A (en) 1991-03-15 1994-01-26 Amgen Inc Compositions of g-csf for pulmonary administration.
US5451569A (en) 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
US5843705A (en) 1995-02-21 1998-12-01 Genzyme Transgenic Corporation Transgenically produced antithrombin III
US6268487B1 (en) 1996-05-13 2001-07-31 Genzyme Transgenics Corporation Purification of biologically active peptides from milk
US20050271660A1 (en) * 2002-09-06 2005-12-08 Alexion Pharmaceuticals, Inc. Nebulization of monoclonal antibodies for treating pulmonary diseases
US20060292213A1 (en) * 2004-06-23 2006-12-28 Myogen, Inc. Enoximone formulations and their use in the treatment of PDE-III mediated diseases
CA2598528A1 (en) * 2005-03-11 2006-09-14 Fresenius Kabi Deutschland Gmbh Production of bioactive glycoproteins from inactive starting material
US20070037192A1 (en) * 2005-07-25 2007-02-15 Gtc Biotherapeutics, Inc. Method of purifying recombinant human antithrombin to enhance the viral and prion safety profile
US7521632B2 (en) 2006-08-31 2009-04-21 Gaton Corporation Door hinge assembly and enclosure employing the same

Also Published As

Publication number Publication date
KR20140135219A (ko) 2014-11-25
US20140206617A1 (en) 2014-07-24
CN104321076A (zh) 2015-01-28
CA2871159A1 (en) 2013-09-19
WO2013138271A1 (en) 2013-09-19
EP2825194A1 (en) 2015-01-21
JP2015509984A (ja) 2015-04-02
EP2825194A4 (en) 2015-10-21
IN2014DN08385A (enExample) 2015-05-08
AU2013203512A1 (en) 2013-09-26
TW201400499A (zh) 2014-01-01
AU2013203512B2 (en) 2016-02-25
AR090315A1 (es) 2014-11-05

Similar Documents

Publication Publication Date Title
MX2014010940A (es) El uso de antitrombina en el tratamiento de preeclampsia.
HK1220980A1 (zh) 用於治疗庞贝氏症的方法和组合物
TW201611843A (en) Methods of treatment with arginine deiminase
AU2011328009A8 (en) Compounds and methods for treating pain
WO2012092336A3 (en) Molecular profiling for cancer
WO2014089241A3 (en) Molecular profiling for cancer
MX2014012477A (es) Inhibidores pirrolopirazona de tanquirasa.
MX370573B (es) Monoterapia con glucopiranosil lipido a para usarse en el tratamiento del cancer.
IN2015DN01156A (enExample)
PH12015502042A1 (en) Use of linagliptin in cardio-and renoprotective antidiabetic therapy
MX2015006478A (es) Inhibidores de glutaminasa y metodos de empleo.
MX2013012253A (es) Conjugados novedosos de aglutinante-farmaco (adc) y su uso.
MX356525B (es) Vectores de virus asociados con adeno (aav) para uso en terapia de genes de coroideremia.
WO2015009726A3 (en) Medical uses of cd38 agonists
AU2011338383A8 (en) Treatment of HER2-positive cancer with paclitaxel and trastuzumab-MCC-DM1
EA201490559A1 (ru) Композиция для лечения свища
NZ628433A (en) Chitosan-derived compositions
MY161601A (en) Films and compositions comprising the same
GB2525835A (en) Composition comprising a diindolymethane and a retinoid to treat a skin condition
MX359181B (es) Hidrolizado de colágeno y uso del mismo.
IN2014KN02914A (enExample)
MX2014012535A (es) Terapia de combinacion de anticuerpos anti-mif y quimioterapeuticos.
EP3449917A3 (en) Tapentadol for preventing chronification of pain
MX362111B (es) Un metodo para mejorar la funcion hepatica.
MX2013009456A (es) Compuestos de azufre aromaticos sustituidos y metodos para su uso.